Cancel

Magazine Contents

Xarelto® - New Approved Indication Prevention of stroke and systemic embolism
in adult patients with non-valvular
atrial fibrillation (SPAF)
First Approved New Oral Anticoagulant DVT Treatment and Prevention of Recurrent
DVT/PE
Current and Emerging Oral Anticoagulants: Rational Drug Design or Just Luck?
History of Warfarin
Xarelto® - Now approved in the EU across three indications in the area of Venous and Arterial Thromboembolism


VATspace Videos

History of Warfarin
Atrial Fibrillation Explained
Atrial Fibrillation, Clot Formation and Stroke

© 2012, Bayer Pharma AG
This website is intended to provide information to an
international audience outside the USA and UK.

•  Imprint   •   CONDITIONS OF USE   •   PRIVACY STATEMENT   •   Prescribing information   •

Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

If you are not a healthcare professional please visit our patient site.

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in